The US Spinal Surgery Market Outlook to 2017 - Ageing population and Technological Advances to Intensify the Competition
The report titled ‘The US Spinal Surgery Market Outlook to 2017- Ageing population and Technological Advances to Intensify the Competition’ provides a comprehensive analysis of the various aspects such as market size, segmentation, trends and developments and future projections of the spinal implants and procedures to treat spinal disorders which includes the posterior pedicle screw systems, allografts, anterior cervical plate systems, vertebroplasty systems, anterior lumbar interbody fusion devices and ten other spinal devices as key segments of the market. The report provides the market share and company profiles of major players in major segments..
In 2011, over 5 million people suffered from some type of chronic back pain in the US. The prescribed treatment for the back pain depends on the severity and duration of the disorder. In order to maintain the level of physical activity, the elderly people aged above 60 in the US has an increased demand for the treatment of the back pain using surgeries involving less pain and quicker recovery. This has contributed to a significant growth in the spinal industry. One of the principal reasons of the healthcare expenditure in the US is back pain with a direct cost of USD 50 billion annually for diagnosis, treatment and rehabilitation.
The US spinal surgery market has experienced a remarkable growth trajectory over the years. The revenues grew from USD ~ million in 2007 to USD ~ million in 2012, registering a CAGR of 5.8%. This development in the market revenue was due to the augmentation in the age-related disorders and deformities in spine. Additionally, the incorporation of MIS techniques and orthobiologics the spinal surgery market in the US has experienced a significant growth. The rise in demand by the patients for the treatment that helps in resuming quickly to the active lifestyle has driven the market over the period.
The US spinal surgery market has been dominated largely by the posterior pedicle screw fusion systems with a contribution of 24.7% in 2012. The pedicle screws have been majorly used by the surgeons in the surgeries involving fusion of bones.
The US allografts market has observed a healthy growth from 2007 to 2012 and accounts for the second largest segment in the US spinal surgery market. Allografts have been reported to give results equivalent to the surgeries in which autografts are used. The demand for allografts is increasing rapidly, driven by the increase in the number of fusion surgeries carried in the US. The US allograft market has witnessed growth in revenues from USD ~ million in 2007 to USD ~ million in 2012. The US allograft market has recorded consistent growth at a CAGR of 6.5% during 2007-2012.
The advent of orthobiologics in the spinal industry is estimated to further add changes in the market. Due to technological advancements, the US spine industry is expected to witness a transition from the application of mechanical implants to biological implants. The use of allografts, demineralized bone matrix (DBM) and bone morphogenetic proteins (BMP) in the surgeries has helped the patients in a faster recovery with less postoperative pain. The orthobiologics segment is likely grow in the future due to an increase in ageing population of the US that will demand for the procedures involving a fast recovery and a quality treatment.
The introduction of the minimally invasive axial lumbar interbody fusion technique has affected the traditional interbody surgeries. The growth of this market remained steady from the period 2007 to 2011 experiencing an incline in the revenues from USD ~ million in 2007 to USD ~ million in 2011. The US AxiaLIF devices market clocked revenues of USD ~million in 2012 and has grown at a CAGR 17.7% from 2007 to 2012.
The US spinal surgery market is largely dominated by Medtronic which accounted for 38.5% of the total spinal surgery market in the US in 2012. With a market share of 11.2% DePuy was the second largest major player in the US spinal surgery market and has generated revenues worth of USD ~ million in 2012. NuVasive was the third largest leading player in the US spinal surgery market which recorded revenues of USD ~million in 2012 and held a market share of 10%.
It is estimated that US spinal surgery market revenues will reach USD ~ million by 2017 and is expected to grow at a CAGR of 4.8% from 2013 to 2017. The revenues are estimated to largely be driven from the treatment of elderly patients in the US suffering from spine ailments.
KEY TOPICS COVERED IN THE REPORT
In 2011, over 5 million people suffered from some type of chronic back pain in the US. The prescribed treatment for the back pain depends on the severity and duration of the disorder. In order to maintain the level of physical activity, the elderly people aged above 60 in the US has an increased demand for the treatment of the back pain using surgeries involving less pain and quicker recovery. This has contributed to a significant growth in the spinal industry. One of the principal reasons of the healthcare expenditure in the US is back pain with a direct cost of USD 50 billion annually for diagnosis, treatment and rehabilitation.
The US spinal surgery market has experienced a remarkable growth trajectory over the years. The revenues grew from USD ~ million in 2007 to USD ~ million in 2012, registering a CAGR of 5.8%. This development in the market revenue was due to the augmentation in the age-related disorders and deformities in spine. Additionally, the incorporation of MIS techniques and orthobiologics the spinal surgery market in the US has experienced a significant growth. The rise in demand by the patients for the treatment that helps in resuming quickly to the active lifestyle has driven the market over the period.
The US spinal surgery market has been dominated largely by the posterior pedicle screw fusion systems with a contribution of 24.7% in 2012. The pedicle screws have been majorly used by the surgeons in the surgeries involving fusion of bones.
The US allografts market has observed a healthy growth from 2007 to 2012 and accounts for the second largest segment in the US spinal surgery market. Allografts have been reported to give results equivalent to the surgeries in which autografts are used. The demand for allografts is increasing rapidly, driven by the increase in the number of fusion surgeries carried in the US. The US allograft market has witnessed growth in revenues from USD ~ million in 2007 to USD ~ million in 2012. The US allograft market has recorded consistent growth at a CAGR of 6.5% during 2007-2012.
The advent of orthobiologics in the spinal industry is estimated to further add changes in the market. Due to technological advancements, the US spine industry is expected to witness a transition from the application of mechanical implants to biological implants. The use of allografts, demineralized bone matrix (DBM) and bone morphogenetic proteins (BMP) in the surgeries has helped the patients in a faster recovery with less postoperative pain. The orthobiologics segment is likely grow in the future due to an increase in ageing population of the US that will demand for the procedures involving a fast recovery and a quality treatment.
The introduction of the minimally invasive axial lumbar interbody fusion technique has affected the traditional interbody surgeries. The growth of this market remained steady from the period 2007 to 2011 experiencing an incline in the revenues from USD ~ million in 2007 to USD ~ million in 2011. The US AxiaLIF devices market clocked revenues of USD ~million in 2012 and has grown at a CAGR 17.7% from 2007 to 2012.
The US spinal surgery market is largely dominated by Medtronic which accounted for 38.5% of the total spinal surgery market in the US in 2012. With a market share of 11.2% DePuy was the second largest major player in the US spinal surgery market and has generated revenues worth of USD ~ million in 2012. NuVasive was the third largest leading player in the US spinal surgery market which recorded revenues of USD ~million in 2012 and held a market share of 10%.
It is estimated that US spinal surgery market revenues will reach USD ~ million by 2017 and is expected to grow at a CAGR of 4.8% from 2013 to 2017. The revenues are estimated to largely be driven from the treatment of elderly patients in the US suffering from spine ailments.
KEY TOPICS COVERED IN THE REPORT
- Spinal disorders and disease classification
- The US spinal surgery market size.
- The market segmentation of the US spinal sugery market by type of the devices.
- The market size, future outlook and projections of the posterior pedicle screw fusion systems market in the US.
- The market size, future outlook and projections of the anterior cervical and thoracolumbar plate systems market in the US.
- The market size of the anterior and posterior lumbar interbody fusion devcies market in the US.
- Future outlook and projections of the anterior and posterior lumbar interbody fusion devices in the US
- The market size of the transforaminal and axial lumbar interbody fusion devices market in the US
- Future outlook and projections of the transforaminal and axial lumbar interbody fusion devices market in the US.
- Market size, future outlook and projections of the cervical and lumbar artificial discs in the US
- Market size, future outlook and projections of the vertebroplasty and balloon kyphoplasty market in the US.
- Market size, future outlook and projections of the allografts, demineralized bone matrices and bone morphogenetic proteins market in the US.
- Trends and developments of the US spinal surgery market
- Market share of major players in the US spinal surgery market.
- Profiles of major players in the spinal surgery market in the US
- Future outlook and projections of the spinal surgery market in the US.
1. THE US SPINAL SURGERY MARKET INTRODUCTION
2. SPINAL DISORDER AND DISEASE CLASSIFICATION
3. SPINAL SURGERIES
3.1. Traditional Spine Surgery
3.2. Minimal Invasive Spine Surgery
4. THE US SPINAL SURGERY MARKET SIZE, 2007-2012
5. THE US SPINAL SURGERY MARKET SEGMENTATION, 2007-2012
5.1. The US Posterior Pedicle Screw Fusion Systems Market, 2007-2012
5.1.1. The US Posterior Pedicle Screw Fusion Systems Market Size, 2007-2012
Average Selling Price for Pedicle Screw Systems
5.1.2. The US Posterior Pedicle Screw Fusion System Market Future Outlook and Projections, 2013-2017
5.2. The US Anterior Cervical Plate Systems Market, 2007-2012
5.2.1. The US Anterior Cervical Plate System Market Size, 2007-2012
Average Selling Price for Anterior Cervical Plate System
5.2.2. The US Anterior Cervical Plate System Market Future Outlook and Projections, 2013-2017
5.3. The US Anterior Thoracolumbar Plate Systems Market, 2007-2012
5.3.1. The US Anterior Thoracolumbar Plate Systems Market Size, 2007-2012
Average Selling Price for Anterior Thoracolumbar Plate Systems
5.3.2. The US Anterior Thoracolumbar Plate Systems Market Future Outlook and Projections, 2013-2017
5.4. The US Anterior Lumbar Interbody Fusion Devices Market, 2007-2012
5.4.1. The US Anterior Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.4.2. The US Anterior Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.5. The US Transforaminal Lumbar Interbody Fusion Devices Market, 2007-2012
5.5.1. The US Transforaminal Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.5.2. The US Transforaminal Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.6. The US Posterior Lumbar Interbody Fusion Devices Market, 2007-2012
5.6.1. The US Posterior Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.6.2. The US Posterior Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.7. The US Axial Lumbar Interbody Fusion Devices Market, 2007-2012
5.7.1. The US Axial Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.7.2. The US Axial Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.8. The US Interspinous Process Spacers Market, 2007-2012
5.8.1. The US Interspinous Process Spacers Market Size, 2007-2012
Average Selling Price for Interspinious Process Spacers
5.8.2. The US Interspinous Process Spacers Market Future Outlook and Projections, 2013-2017
5.9. The US Cervical Artificial Discs Market, 2007-2012
5.9.1. The US Cervical Artificial Discs Market Size, 2007-2012
Average Selling Price for Cervical Artificial Discs
5.9.2. The US Cervical Artificial Discs Market Future Outlook and Projections, 2013-2017
5.10. The US Lumbar Artificial Discs Market, 2007-2012
5.10.1. The US Lumbar Artificial Discs Market Size, 2007-2012
Average Selling Price of Lumbar Artificial Discs
5.10.2. The US Lumbar Artificial Discs Market Future Outlook and Projections, 2013-2017
5.11. The US Vertebroplasty Market, 2007-2012
5.11.1. The US Vertebroplasty Market Size, 2007-2012
5.11.2. The US Vertebroplasty Market Future Outlook and Projections, 2013-2017
5.12. The US Balloon Kyphoplasty Market, 2007-2012
5.12.1. The US Balloon Kyphoplasty Market Size, 2007-2012
Average Selling Price for the Systems for Vertebral Compression Fractures
5.12.2. The US Balloon Kyphoplasty Market Future Outlook and Projections, 2013-2017
5.13. The US Allografts Market, 2007-2012
5.13.1. The US Allografts Market Size, 2007-2012
5.13.2. The US Allografts Market Future Outlook and Projections, 2013-2017
5.14. The US Demineralized Bone Matrices Market, 2007-2012
5.14.1. The US Demineralized Bone Matrices Market Size, 2007-2012
5.14.2. The US Demineralized Bone Matrices Market Future Outlook and Projections, 2013-2017
5.15. The US Bone Morphogenic Proteins Market, 2007-2012
5.15.1. The US Bone Morphogenic Proteins Market Size, 2007-2012
Medtronic Infuse Bonegrafts and their Affect on the US Spinal Surgery Market
5.15.2. The US Bone Morphogenic Proteins Market Future Outlook and Projections, 2013-2017
6. THE US SPINAL SURGERY MARKET TRENDS AND DEVELOPMENTS
The Traditional Complex Procedures have Turned Minimally Invasive
Incorporation of Specialists to Provide Effective Spinal Care
With the Advent of Biologics the Fusion is Easily Achieved Causing Less Pain to the Patient
Growth Potential of New Technology in Spine Surgeries
7. MARKET SHARE OF MAJOR PLAYERS IN THE US SPINAL SURGERY MARKET, 2008-2012
7.1. Market Share of Major Players in the US Spinal Surgery Market, 2008-2012
7.2. Market Share of Major Players by Segments, 2007-2012
7.2.1. Market Share of Major Players for Spinal Plate and Screw Systems, 2007-2012
7.2.2. Market Share of Major Players for Pedicle Screw System, 2007-2012
7.2.3. Market Share of Major Players for Interbody Fusion Devices, 2007-2012
8. COMPANY PROFILES OF MAJOR PLAYERS IN THE US SPINAL SURGERY MARKET
8.1. Medtronics
8.1.1. Company Overview
8.1.2. Financial Performance, 2007-2012
8.1.3. Business Strategy
Focus on Increased Research and Development expenditure
Growth through Mergers and Acquisitions
8.2. DePuy Synthes
8.2.1. Company Overview
8.2.2. Financial Performance, 2007-2012
8.2.3. Business Strategy
Focus on Increasing Global Presence
Focus on the Development of New Products
8.3. NuVasive
8.3.1. Company Overview
8.3.2. Financial Performance, 2008-2012
8.3.3. Business Strategy
Launch of Maximum Access Surgery (MAS) as the Measure of Care
Focus on Development of New Products
Focus on Expanding the Reach of Sales Group
Focus on Selective Licensing of the Spine Products and Technology
8.4. Stryker
8.4.1. Company Overview
8.4.2. Financial Performance, 2007-2012
8.4.3. Business Strategy
Focus on the Development of Innovative Products
Growth through Acquisitions
8.5. Globus Medical
8.5.1. Company Overview
8.5.2. Financial Performance, 2008-2012
8.5.3. Business Strategy
New Products Under Development Stage
Increase the Scope and Productivity of the U.S. Sales Force
9. THE US SPINAL SURGERY MARKET FUTURE OUTLOOK AND PROJECTIONS, 2013-2017
9.1. Cause and Effect Relationship between the Industry Factors and the US Spinal Surgery Market
9.2. The US Spinal Surgery Market Future Outlook and Projections, 2013-2017
10. MACROECONOMIC AND INDUSTRY FACTORS: HISTORICAL AND PROJECTIONS
10.1. Population in the US, 2007-2017
10.2. Ageing Population in the US (above 65 years), 2007-2017
10.3. People in the US with BMI 25 and above Aged 18 years and above, 2007-2017
10.4. Personal Disposable Income in the US, 2007-2017
10.5. The US Health Insurance Market, 2007-2017
10.6. The US Health Expenditure, 2007-2017
11. APPENDIX
11.1. Market Definition
11.2. Abbreviations
11.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
11.4. Disclaimer
2. SPINAL DISORDER AND DISEASE CLASSIFICATION
3. SPINAL SURGERIES
3.1. Traditional Spine Surgery
3.2. Minimal Invasive Spine Surgery
4. THE US SPINAL SURGERY MARKET SIZE, 2007-2012
5. THE US SPINAL SURGERY MARKET SEGMENTATION, 2007-2012
5.1. The US Posterior Pedicle Screw Fusion Systems Market, 2007-2012
5.1.1. The US Posterior Pedicle Screw Fusion Systems Market Size, 2007-2012
Average Selling Price for Pedicle Screw Systems
5.1.2. The US Posterior Pedicle Screw Fusion System Market Future Outlook and Projections, 2013-2017
5.2. The US Anterior Cervical Plate Systems Market, 2007-2012
5.2.1. The US Anterior Cervical Plate System Market Size, 2007-2012
Average Selling Price for Anterior Cervical Plate System
5.2.2. The US Anterior Cervical Plate System Market Future Outlook and Projections, 2013-2017
5.3. The US Anterior Thoracolumbar Plate Systems Market, 2007-2012
5.3.1. The US Anterior Thoracolumbar Plate Systems Market Size, 2007-2012
Average Selling Price for Anterior Thoracolumbar Plate Systems
5.3.2. The US Anterior Thoracolumbar Plate Systems Market Future Outlook and Projections, 2013-2017
5.4. The US Anterior Lumbar Interbody Fusion Devices Market, 2007-2012
5.4.1. The US Anterior Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.4.2. The US Anterior Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.5. The US Transforaminal Lumbar Interbody Fusion Devices Market, 2007-2012
5.5.1. The US Transforaminal Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.5.2. The US Transforaminal Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.6. The US Posterior Lumbar Interbody Fusion Devices Market, 2007-2012
5.6.1. The US Posterior Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.6.2. The US Posterior Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.7. The US Axial Lumbar Interbody Fusion Devices Market, 2007-2012
5.7.1. The US Axial Lumbar Interbody Fusion Devices Market Size, 2007-2012
5.7.2. The US Axial Lumbar Interbody Fusion Devices Market Future Outlook and Projections, 2013-2017
5.8. The US Interspinous Process Spacers Market, 2007-2012
5.8.1. The US Interspinous Process Spacers Market Size, 2007-2012
Average Selling Price for Interspinious Process Spacers
5.8.2. The US Interspinous Process Spacers Market Future Outlook and Projections, 2013-2017
5.9. The US Cervical Artificial Discs Market, 2007-2012
5.9.1. The US Cervical Artificial Discs Market Size, 2007-2012
Average Selling Price for Cervical Artificial Discs
5.9.2. The US Cervical Artificial Discs Market Future Outlook and Projections, 2013-2017
5.10. The US Lumbar Artificial Discs Market, 2007-2012
5.10.1. The US Lumbar Artificial Discs Market Size, 2007-2012
Average Selling Price of Lumbar Artificial Discs
5.10.2. The US Lumbar Artificial Discs Market Future Outlook and Projections, 2013-2017
5.11. The US Vertebroplasty Market, 2007-2012
5.11.1. The US Vertebroplasty Market Size, 2007-2012
5.11.2. The US Vertebroplasty Market Future Outlook and Projections, 2013-2017
5.12. The US Balloon Kyphoplasty Market, 2007-2012
5.12.1. The US Balloon Kyphoplasty Market Size, 2007-2012
Average Selling Price for the Systems for Vertebral Compression Fractures
5.12.2. The US Balloon Kyphoplasty Market Future Outlook and Projections, 2013-2017
5.13. The US Allografts Market, 2007-2012
5.13.1. The US Allografts Market Size, 2007-2012
5.13.2. The US Allografts Market Future Outlook and Projections, 2013-2017
5.14. The US Demineralized Bone Matrices Market, 2007-2012
5.14.1. The US Demineralized Bone Matrices Market Size, 2007-2012
5.14.2. The US Demineralized Bone Matrices Market Future Outlook and Projections, 2013-2017
5.15. The US Bone Morphogenic Proteins Market, 2007-2012
5.15.1. The US Bone Morphogenic Proteins Market Size, 2007-2012
Medtronic Infuse Bonegrafts and their Affect on the US Spinal Surgery Market
5.15.2. The US Bone Morphogenic Proteins Market Future Outlook and Projections, 2013-2017
6. THE US SPINAL SURGERY MARKET TRENDS AND DEVELOPMENTS
The Traditional Complex Procedures have Turned Minimally Invasive
Incorporation of Specialists to Provide Effective Spinal Care
With the Advent of Biologics the Fusion is Easily Achieved Causing Less Pain to the Patient
Growth Potential of New Technology in Spine Surgeries
7. MARKET SHARE OF MAJOR PLAYERS IN THE US SPINAL SURGERY MARKET, 2008-2012
7.1. Market Share of Major Players in the US Spinal Surgery Market, 2008-2012
7.2. Market Share of Major Players by Segments, 2007-2012
7.2.1. Market Share of Major Players for Spinal Plate and Screw Systems, 2007-2012
7.2.2. Market Share of Major Players for Pedicle Screw System, 2007-2012
7.2.3. Market Share of Major Players for Interbody Fusion Devices, 2007-2012
8. COMPANY PROFILES OF MAJOR PLAYERS IN THE US SPINAL SURGERY MARKET
8.1. Medtronics
8.1.1. Company Overview
8.1.2. Financial Performance, 2007-2012
8.1.3. Business Strategy
Focus on Increased Research and Development expenditure
Growth through Mergers and Acquisitions
8.2. DePuy Synthes
8.2.1. Company Overview
8.2.2. Financial Performance, 2007-2012
8.2.3. Business Strategy
Focus on Increasing Global Presence
Focus on the Development of New Products
8.3. NuVasive
8.3.1. Company Overview
8.3.2. Financial Performance, 2008-2012
8.3.3. Business Strategy
Launch of Maximum Access Surgery (MAS) as the Measure of Care
Focus on Development of New Products
Focus on Expanding the Reach of Sales Group
Focus on Selective Licensing of the Spine Products and Technology
8.4. Stryker
8.4.1. Company Overview
8.4.2. Financial Performance, 2007-2012
8.4.3. Business Strategy
Focus on the Development of Innovative Products
Growth through Acquisitions
8.5. Globus Medical
8.5.1. Company Overview
8.5.2. Financial Performance, 2008-2012
8.5.3. Business Strategy
New Products Under Development Stage
Increase the Scope and Productivity of the U.S. Sales Force
9. THE US SPINAL SURGERY MARKET FUTURE OUTLOOK AND PROJECTIONS, 2013-2017
9.1. Cause and Effect Relationship between the Industry Factors and the US Spinal Surgery Market
9.2. The US Spinal Surgery Market Future Outlook and Projections, 2013-2017
10. MACROECONOMIC AND INDUSTRY FACTORS: HISTORICAL AND PROJECTIONS
10.1. Population in the US, 2007-2017
10.2. Ageing Population in the US (above 65 years), 2007-2017
10.3. People in the US with BMI 25 and above Aged 18 years and above, 2007-2017
10.4. Personal Disposable Income in the US, 2007-2017
10.5. The US Health Insurance Market, 2007-2017
10.6. The US Health Expenditure, 2007-2017
11. APPENDIX
11.1. Market Definition
11.2. Abbreviations
11.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
11.4. Disclaimer
LIST OF FIGURES
Figure 1: The US Spinal Surgery Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 2: Pedicle Screw Fusion Systems
Figure 3: The US Posterior Pedicle Screw Fusion Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 4: The US Posterior Pedicle Screw Fusion Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 5 : Anterior Cervical Plate Systems
Figure 6: The US Anterior Cervical Plate Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 7: The US Anterior Cervical Plate Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 8 : Anterior Thoracolumbar Plate System
Figure 9: The US Anterior Thoracolumbar Plate Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 10: The US Anterior Thoracolumbar Plate Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 11: Anterior Lumbar Interbody Fusion Systems
Figure 12 : The US Anterior Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 13: The US Anterior Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 14: Transforaminal Lumbar Interbody Fusion System
Figure 15: The US Transforaminal Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 16: The US Transformational Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 17: Posterior Lumbar Interbody Fusion System
Figure 18 : The US Posterior Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 19: The US Posterior Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 20: Axial Lumbar Interbody Fusion System
Figure 21: The US Axial Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 22: The US Axial Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 23 : Interspinous Process Spacers
Figure 24: The US Interspinous Process Spacers Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 25: The US Interspinous Process Spacers Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 26: Cervical Artificial Discs
Figure 27: The US Cervical Artificial Discs Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 28: The Cervical Artificial Discs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 29 : Lumbar Artificial Discs
Figure 30: The US Lumbar Artificial Discs Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 31: The Lumbar Artificial Discs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 32: Vertebroplasty
Figure 33: The US Vertebroplasty Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 34: The Vertebroplasty Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 35: Balloon Kyphoplasty
Figure 36: The US Balloon Kyphoplasty Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 37: The US Balloon Kyphoplasty Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 38: Allografts used in Spinal Surgery
Figure 39: The US Allografts Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 40: The US Allografts Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 41: Demineralized Bone Matrices
Figure 42: The US Demineralized Bone Matrices Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 43: The US Demineralized Bone Matrices Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 44: Bone Morphogenic Proteins
Figure 45 : The US Bone Morphogenic Proteins Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 46: The US Bone Morphogenic Proteins Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 47: Medtronic’s Revenues from the Spinal Segment in USD Million, 2007-2012
Figure 48: DePuy’s Revenues from Spinal Segment in USD Million, 2007-2012
Figure 49: NuVasive’s Revenue from Spinal Segment in USD Million, 2008-2012
Figure 50: Stryker Revenues from Spinal Segment in USD Million, 2007-2012
Figure 51: Globus Medical Revenues from Spinal Segment in USD Million, 2008-2012
Figure 52: The US Spinal Surgery Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 53: Population in US in Million, 2007-2017
Figure 54: Ageing Population (Above 65 years) in the US in Million, 2007-2017
Figure 55: People in the US with BMI 25 and above aged 18 years and above in million, 2007-2017
Figure 56: Personal Disposable Income in the US in USD Million, 2007-2017
Figure 57: The US Health Insurance Market in USD Million, 2007-2017
Figure 58: The US Health Expenditure in USD Million, 2007-2017
Figure 1: The US Spinal Surgery Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 2: Pedicle Screw Fusion Systems
Figure 3: The US Posterior Pedicle Screw Fusion Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 4: The US Posterior Pedicle Screw Fusion Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 5 : Anterior Cervical Plate Systems
Figure 6: The US Anterior Cervical Plate Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 7: The US Anterior Cervical Plate Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 8 : Anterior Thoracolumbar Plate System
Figure 9: The US Anterior Thoracolumbar Plate Systems Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 10: The US Anterior Thoracolumbar Plate Systems Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 11: Anterior Lumbar Interbody Fusion Systems
Figure 12 : The US Anterior Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 13: The US Anterior Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 14: Transforaminal Lumbar Interbody Fusion System
Figure 15: The US Transforaminal Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 16: The US Transformational Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 17: Posterior Lumbar Interbody Fusion System
Figure 18 : The US Posterior Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 19: The US Posterior Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 20: Axial Lumbar Interbody Fusion System
Figure 21: The US Axial Lumbar Interbody Fusion Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 22: The US Axial Lumbar Interbody Fusion Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 23 : Interspinous Process Spacers
Figure 24: The US Interspinous Process Spacers Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 25: The US Interspinous Process Spacers Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 26: Cervical Artificial Discs
Figure 27: The US Cervical Artificial Discs Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 28: The Cervical Artificial Discs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 29 : Lumbar Artificial Discs
Figure 30: The US Lumbar Artificial Discs Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 31: The Lumbar Artificial Discs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 32: Vertebroplasty
Figure 33: The US Vertebroplasty Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 34: The Vertebroplasty Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 35: Balloon Kyphoplasty
Figure 36: The US Balloon Kyphoplasty Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 37: The US Balloon Kyphoplasty Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 38: Allografts used in Spinal Surgery
Figure 39: The US Allografts Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 40: The US Allografts Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 41: Demineralized Bone Matrices
Figure 42: The US Demineralized Bone Matrices Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 43: The US Demineralized Bone Matrices Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 44: Bone Morphogenic Proteins
Figure 45 : The US Bone Morphogenic Proteins Market Size on the Basis of Revenue in USD Million, 2007-2012
Figure 46: The US Bone Morphogenic Proteins Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 47: Medtronic’s Revenues from the Spinal Segment in USD Million, 2007-2012
Figure 48: DePuy’s Revenues from Spinal Segment in USD Million, 2007-2012
Figure 49: NuVasive’s Revenue from Spinal Segment in USD Million, 2008-2012
Figure 50: Stryker Revenues from Spinal Segment in USD Million, 2007-2012
Figure 51: Globus Medical Revenues from Spinal Segment in USD Million, 2008-2012
Figure 52: The US Spinal Surgery Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 53: Population in US in Million, 2007-2017
Figure 54: Ageing Population (Above 65 years) in the US in Million, 2007-2017
Figure 55: People in the US with BMI 25 and above aged 18 years and above in million, 2007-2017
Figure 56: Personal Disposable Income in the US in USD Million, 2007-2017
Figure 57: The US Health Insurance Market in USD Million, 2007-2017
Figure 58: The US Health Expenditure in USD Million, 2007-2017
LIST OF TABLES
Table 1: Spinal Disorder and Disease Classification
Table 2: Traditional Spine Surgery Procedures
Table 3 : Minimal Invasive Spine Surgery Procedures
Table 4: Number of Orthopedic Surgeons in the US in 2010
Table 5: The US Spinal Surgery Market Segmentation by Type on the Basis of Revenue in Percentage, 2007-2012
Table 6: Average Selling Price for Lumbar Pedicle Screw System by Companies in USD, 2010
Table 7: Average Selling Price for Cervical Pedicle Screw System by Companies in USD, 2010
Table 8: Average Selling Price for Anterior Cervical Plate System by Companies in USD, 2010
Table 9: Average Selling Price for Anterior Thoracolumbar Plate System by companies in USD, 2010
Table 10: Average Selling Price for Spinous Process Devices by Companies in USD, 2010
Table 11: Average Selling Price for Cervical Artificial Disc by Companies in USD, 2010
Table 12: Average Selling Price for Lumbar Artificial Disc by DePuy Synthes in USD, 2010
Table 13: Average Selling Price for the System for Vertebral Compression Fractures Repair by Companies in USD, 2010
Table 14:The US Spinal Surgery Market Shares of Major Players on the Basis of Revenue in Percentage, 2008-2012
Table 15: The US Spinal Surgery Market Shares of Major Players on the Basis of Revenue in USD million, 2008-2012
Table 16: Market Shares of Major Players for Spinal Plate and Screw Systems on the Basis of Revenue in Percentage, 2007-2012
Table 17: Market Shares of Major Players for Pedicle Screw Systems on the Basis of Revenue in Percentage, 2007-2012
Table 18: Market Shares of Major Players for Interbody Fusion Devices on the Basis of Revenue in Percentage, 2007-2012
Table 19: Research and Development Expenditure by Medtronic in USD Million, 2007-2012
Table 20: Research and Development Expenditure by NuVasive in USD Million, 2007-2012
Table 21: Research and Development Expenditure by Stryker in USD Million, 2007-2012
Table 22: Cause and Effect Relationship Analysis between the Industry Factors and Expected US Spinal Surgery Market Prospects
Table 23: Correlation Matrix for The US Spinal Surgery Market
Table 24: Regression Coefficients Output
Table 1: Spinal Disorder and Disease Classification
Table 2: Traditional Spine Surgery Procedures
Table 3 : Minimal Invasive Spine Surgery Procedures
Table 4: Number of Orthopedic Surgeons in the US in 2010
Table 5: The US Spinal Surgery Market Segmentation by Type on the Basis of Revenue in Percentage, 2007-2012
Table 6: Average Selling Price for Lumbar Pedicle Screw System by Companies in USD, 2010
Table 7: Average Selling Price for Cervical Pedicle Screw System by Companies in USD, 2010
Table 8: Average Selling Price for Anterior Cervical Plate System by Companies in USD, 2010
Table 9: Average Selling Price for Anterior Thoracolumbar Plate System by companies in USD, 2010
Table 10: Average Selling Price for Spinous Process Devices by Companies in USD, 2010
Table 11: Average Selling Price for Cervical Artificial Disc by Companies in USD, 2010
Table 12: Average Selling Price for Lumbar Artificial Disc by DePuy Synthes in USD, 2010
Table 13: Average Selling Price for the System for Vertebral Compression Fractures Repair by Companies in USD, 2010
Table 14:The US Spinal Surgery Market Shares of Major Players on the Basis of Revenue in Percentage, 2008-2012
Table 15: The US Spinal Surgery Market Shares of Major Players on the Basis of Revenue in USD million, 2008-2012
Table 16: Market Shares of Major Players for Spinal Plate and Screw Systems on the Basis of Revenue in Percentage, 2007-2012
Table 17: Market Shares of Major Players for Pedicle Screw Systems on the Basis of Revenue in Percentage, 2007-2012
Table 18: Market Shares of Major Players for Interbody Fusion Devices on the Basis of Revenue in Percentage, 2007-2012
Table 19: Research and Development Expenditure by Medtronic in USD Million, 2007-2012
Table 20: Research and Development Expenditure by NuVasive in USD Million, 2007-2012
Table 21: Research and Development Expenditure by Stryker in USD Million, 2007-2012
Table 22: Cause and Effect Relationship Analysis between the Industry Factors and Expected US Spinal Surgery Market Prospects
Table 23: Correlation Matrix for The US Spinal Surgery Market
Table 24: Regression Coefficients Output
